TXMD
TherapeuticsMD Inc
NASDAQ: TXMD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.16
+2.86% today
Updated 2026-09-11
Market cap
$25.58M
P/E ratio
—
P/S ratio
7.82x
EPS (TTM)
$-0.03
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
TherapeuticsMD Inc (TXMD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$2.16
12-Month target
$0.07
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -6.64%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.